Steve Postal News Today

NCPA staff Steve Postal joined the American Society for Pharmacy Law (ASPL) as its new editorial director, and is editing ASPL’s Latest News, E-News, and Rx Ipsa Loquitur publications. ASPL is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties. Steve has presented twice at ASPL events and has bee...

NCPA staff Steve Postal joined APhA and NACDS last week in a meeting with DEA staff to discuss pharmacy access to medication for opioid use disorder (MOUD) and pharmacy burglaries.

While calling for a Palestinian state, the Biden administration and the EU are advocating for no less than endless war.

American Muslim women from the American Muslim and Multifaith Women’s Empowerment Council traveled to Israel.

This Saturday, Oct. 28, Total Pharmacy will be hosting an online Solutions Summit focused on leveraging technology to increase pharmacy revenue. Kicking off the event will be Steve Postal, director of policy and regulatory affairs at NCPA, who will be providing a law and advocacy update to folks tuning in. More details, including the agenda and information on how to register, are available here.

NCPA staff Ronna Hauser and Steve Postal joined the leadership of ASCP, PharMerica, Premier, and MHA in advocating for long-term care pharmacy services in the home in a meeting with CMS. Representing the NCPA LTC Division and the Alliance for LTC Pharmacy @ Home, Hauser and Postal discussed the value proposition of LTC pharmacy at home, echoed by the other alliance members, and participated in a discussion of policy proposals related to Medicare Part D and Medicare Advantage.

Steve Postal, NCPA’s director of policy and regulatory affairs, spoke at a panel discussion on beneficiary access to care organized by the patient advocacy group Patients Rising. He was joined on his panel by a beneficiary, two representatives of Concierge Nurse Navigators, and a direct primary care physician.

On Jun 15, NCPA staff Steve Postal and NCPA members Steve Hoffart and Cheri Garvin will participate in the FDA’s annual listening session by speaking about compounding. Hoffart and Garvin will each be giving 5-minute statements.

On June 15, NCPA will be represented at FDA’s annual listening session on compounding by NCPA staff Steve Postal and NCPA members — and meeting presenters — Steve Hoffart and Cheri Garvin. NCPA submitted its written statement for the record ahead of the listening session on compounding, covering concerns with GFI #256 (compounding animal drugs from bulk substances), patient access to compounded bioidentical hormone therapy, drug shortages, and adverse event reporting.

Ties among Abraham Accords nations are growing stronger despite the normalization agreements’ lack of popularity among many people in the Arab partner countries. This is according to the …